Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guerrant Associates is a private investor relations and corporate communications advisory firm rather than a drug developer or healthcare operating company. The firm provides financial communications, investor relations, financial media relations, crisis communications, IPO and M&A communications support, and strategic counsel to public and pre-public companies. Public descriptions indicate that it has served clients across multiple sectors, including technology, industrials, and life sciences, but its own business is professional services rather than therapeutics, diagnostics, or medical products. For biotech analysts, Guerrant Associates is best understood as an external IR and communications partner that may support life sciences companies with capital markets and messaging activities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guerrant Associates.